Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02341053 · ClinicalTrials.gov registry record · NA

Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy

A NA study of Spinal Muscular Dystrophy and Neuromuscular Disability, sponsored by Gillette Children's Specialty Healthcare.

Completed
Registry status
NA
Development phase
4
Enrollment target
1
Study location

NCT02341053: Completed NA study of Spinal Muscular Dystrophy and Neuromuscular Disability, sponsored by Gillette Children's Specialty Healthcare.

NCT02341053 is a NA study of Spinal Muscular Dystrophy and Neuromuscular Disability that has completed, run by Gillette Children's Specialty Healthcare. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02341053, a NA study of Spinal Muscular Dystrophy and Neuromuscular Disability, has completed, sponsored by Gillette Children's Specialty Healthcare.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target
1
Study location

Study Summary

Non-ambulatory children with a neuromuscular disability such as spinal muscular atrophy (SMA) are at significant risk for poor bone health as defined by low bone mineral density (BMD) and increased propensity to fracture. Poor bone health is thought to be related, at least in part, to abnormally low levels of load experienced by the skeleton. A common physical approach for increasing bone density is to stimulate the musculoskeletal system by increasing the amount and duration of weight-bearing in the lower extremities. For non-ambulatory individuals, this takes the form of using an assisted standing device to enable the child to spend time in a standing position with some degree of weight placed on the lower limbs. Some of these physical interventions demonstrate variable improvement in BMD in children with neuromuscular conditions, and some do not. A serious limitation in the previous work in this area is a failure to objectively measure the magnitude and duration of the loading experienced by the lower extremities. Thus, a lack of change in BMD may be due to the extremities experiencing only a fraction of the body weight (due to load-sharing with the assistive device) for an inadequate duration of standing time. In order to investigate the efficacy of standing treatment for increasing BMD, the investigators will develop a simple, portable and inexpensive transducer that will measure the magnitude and time course of the load experienced by the lower extremities of individuals with SMA who use a stationary assisted standing device. The specific goal of this proposed project will be to develop, validate and establish the initial feasibility of such a measurement device.

Primary Outcome

Use load-sensing platforms to collect load magnitude and duration during standing treatment program.

Interventions

  • OTHER Assisted Standing Treatment Program

Study Locations (1)

Minnesota

  • Gillette Children's Specialty Healthcare - Saint Paul

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2016-09-08
Est. Completion 2018-07-25
Phase NA

What the finished NCT02341053 record still lists

NCT02341053 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Spinal Muscular Dystrophy appearing as the primary indexed condition, and to 1 intervention - of which Assisted Standing Treatment Program is the first listed.

NCT02341053 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT02341053 about?

NCT02341053 is a clinical study titled "Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy". Non-ambulatory children with a neuromuscular disability such as spinal muscular atrophy (SMA) are at significant risk for poor bone health as defined by low bone mineral density (BMD) and increased propensity to fracture. Poor bone health is thought to be related, at least in part, to abnormally low...

What is the current status of trial NCT02341053?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2016-09-08. Estimated completion is 2018-07-25.

What conditions does trial NCT02341053 study?

This clinical trial studies the following conditions: Spinal Muscular Dystrophy, Neuromuscular Disability.

What interventions are being tested in trial NCT02341053?

The interventions under investigation include: Assisted Standing Treatment Program (OTHER).

Who is sponsoring clinical trial NCT02341053?

This trial is sponsored by Gillette Children's Specialty Healthcare, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02341053 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT02341053's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02341053, the US trial registry maintained by the National Library of Medicine. NCT02341053 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.